Corcept Therapeutics (CORT) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $113.98 +2.11%
Revenue Growth %: +54.6%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
CULP, KFY, NNOX, More
Revenue Growth %: +54.6%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
CULP, KFY, NNOX, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $12 million versus the consensus estimate of $11.67 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Barnes & Noble Education (BNED) Tops Q1 EPS by 12c
- JPMorgan Downgrades AVI Limited (AVI:SJ) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
